https://business.financialpost.com/pmn/press-releases-pmn/business-wire-news-releases-pmn/samsung-bioepis-announces-phase-3-results-of-sb8-bevacizumab-biosimilar-candidate-at-the-european-society-for-medical-oncology-esmo-2019-congress
ʂ̃TCgɃWv悤ƂĂ܂BXΏL̃NNbNĂ
UPLIFTōLȂő̌܂傤IKȉ{Ct܂I